Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Roszik

Showing results (51-60 of 166) with videos related to

Pageof 17
Sort By:
Pigment Cell & Melanoma Research|November 21, 2018
The lncRNA RMEL3 protects immortalized cells from serum withdrawal-induced growth arrest and promotes melanoma cell proliferation and tumor growthCibele Cardoso, Rodolfo B Serafim, Akinori Kawakami, et al.
Molecular Cancer Therapeutics|July 27, 2016
Hypoxia-Driven Mechanism of Vemurafenib Resistance in MelanomaYong Qin, Jason Roszik, Chandrani Chattopadhyay, et al.
Current Oncology Reports|March 28, 2018
Mesenchymal Chondrosarcoma: a Review with Emphasis on its Fusion-Driven BiologyMarc El Beaino, Jason Roszik, John A Livingston, et al.
JCO Clinical Cancer Informatics|January 18, 2019
High-Throughput Architecture for Discovering Combination Cancer TherapeuticsMatt Gianni, Yong Qin, Geert Wenes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 13, 2018
The COX2 Effector Microsomal PGE2 Synthase 1 is a Regulator of Immunosuppression in Cutaneous MelanomaSun-Hee Kim, Jason Roszik, Sung-Nam Cho, et al.
Plos One|March 23, 2023
Combining MEK and SRC inhibitors for treatment of colorectal cancer demonstrate increased efficacy in vitro but not in vivoFan Fan, Susmita Ghosh, Reid Powell, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2016
NLRC5/MHC class I transactivator is a target for immune evasion in cancerSayuri Yoshihama, Jason Roszik, Isaac Downs, et al.
Cancers|December 23, 2022
Targeting IRS-1/2 in Uveal Melanoma Inhibits In Vitro Cell Growth, Survival and Migration, and In Vivo Tumor GrowthChandrani Chattopadhyay, Rajat Bhattacharya, Jason Roszik, et al.
Biochemical and Biophysical Research Communications|June 26, 2017
Biophysical characterization of histone H3.3 K27M point mutationSzabolcs Hetey, Beáta Boros-Oláh, Tímea Kuik-Rózsa, et al.
Iscience|May 22, 2023
Loss of AMPKα2 promotes melanoma tumor growth and brain metastasisPing Yuan, Da Teng, Evelyn de Groot, et al.
Pageof 17

Showing results (51-60 of 166) with videos related to

Sort By:
Pageof 17
Pigment Cell & Melanoma Research|November 21, 2018
The lncRNA RMEL3 protects immortalized cells from serum withdrawal-induced growth arrest and promotes melanoma cell proliferation and tumor growthCibele Cardoso, Rodolfo B Serafim, Akinori Kawakami, et al.
Molecular Cancer Therapeutics|July 27, 2016
Hypoxia-Driven Mechanism of Vemurafenib Resistance in MelanomaYong Qin, Jason Roszik, Chandrani Chattopadhyay, et al.
Current Oncology Reports|March 28, 2018
Mesenchymal Chondrosarcoma: a Review with Emphasis on its Fusion-Driven BiologyMarc El Beaino, Jason Roszik, John A Livingston, et al.
JCO Clinical Cancer Informatics|January 18, 2019
High-Throughput Architecture for Discovering Combination Cancer TherapeuticsMatt Gianni, Yong Qin, Geert Wenes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 13, 2018
The COX2 Effector Microsomal PGE2 Synthase 1 is a Regulator of Immunosuppression in Cutaneous MelanomaSun-Hee Kim, Jason Roszik, Sung-Nam Cho, et al.
Plos One|March 23, 2023
Combining MEK and SRC inhibitors for treatment of colorectal cancer demonstrate increased efficacy in vitro but not in vivoFan Fan, Susmita Ghosh, Reid Powell, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2016
NLRC5/MHC class I transactivator is a target for immune evasion in cancerSayuri Yoshihama, Jason Roszik, Isaac Downs, et al.
Cancers|December 23, 2022
Targeting IRS-1/2 in Uveal Melanoma Inhibits In Vitro Cell Growth, Survival and Migration, and In Vivo Tumor GrowthChandrani Chattopadhyay, Rajat Bhattacharya, Jason Roszik, et al.
Biochemical and Biophysical Research Communications|June 26, 2017
Biophysical characterization of histone H3.3 K27M point mutationSzabolcs Hetey, Beáta Boros-Oláh, Tímea Kuik-Rózsa, et al.
Iscience|May 22, 2023
Loss of AMPKα2 promotes melanoma tumor growth and brain metastasisPing Yuan, Da Teng, Evelyn de Groot, et al.
Pageof 17